Pharmala Biotech Holdings Inc (MDMA)

Currency in CAD
0.12
-0.01(-3.85%)
Closed·
MDMA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MDMA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.120.14
52 wk Range
0.070.34
Key Statistics
Bid/Ask
0.08 / 0.09
Prev. Close
0.08
Open
0.13
Day's Range
0.12-0.14
52 wk Range
0.07-0.34
Volume
78.64K
Average Volume (3m)
269.06K
1-Year Change
38.89%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MDMA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

Pharmala Biotech Holdings Inc Company Profile

Pharmala Biotech Holdings Inc., doing business as PharmAla, a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredients under the LaNeo brand. The company is headquartered in Vancouver, Canada.

0
Market
Canada

Pharmala Biotech Holdings Inc Earnings Call Summary for Q1/2025

  • Q1 2024 revenue surged 95% YoY to over $1M, driven by 73% growth in MDMA product sales
  • Secured $1.5M through private placement; seeking non-dilutive funding for phase two clinical trials
  • Terminated supply agreement; formed new partnership with RAIN Pharmaceuticals for U.S. market expansion
  • Expects to announce new funding partnerships within 3 months; exploring opportunities with VA and Defense Health Agency
  • Stock up 200% in 6 months; InvestingPro awards "Excellent" Financial Health Score of 4.04
Last Updated: 06/02/2025, 23:14
Read Full Transcript

Compare MDMA to Peers and Sector

Metrics to compare
MDMA
Peers
Sector
Relationship
P/E Ratio
−6.8x−8.1x−0.6x
PEG Ratio
0.04−0.010.00
Price/Book
5.0x0.6x2.6x
Price / LTM Sales
32.9x2.0x3.3x
Upside (Analyst Target)
-100.7%39.0%
Fair Value Upside
Unlock12.6%4.9%Unlock

Earnings

Latest Release
Jul 25, 2025
EPS / Forecast
-- / --
Revenue / Forecast
135.17K / --
EPS Revisions
Last 90 days

MDMA Income Statement

FAQ

What Stock Exchange Does Pharmala Biotech Holdings Trade On?

Pharmala Biotech Holdings is listed and trades on the Canadian Securities Exchange stock exchange.

What Is the Stock Symbol for Pharmala Biotech Holdings?

The stock symbol for Pharmala Biotech Holdings is "MDMA."

What Is the Pharmala Biotech Holdings Market Cap?

As of today, Pharmala Biotech Holdings market cap is 14.39M.

What Is Pharmala Biotech Holdings's Earnings Per Share (TTM)?

The Pharmala Biotech Holdings EPS (TTM) is -0.02.

From a Technical Analysis Perspective, Is MDMA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Pharmala Biotech Holdings Stock Split?

Pharmala Biotech Holdings has split 0 times.

How Many Employees Does Pharmala Biotech Holdings Have?

Pharmala Biotech Holdings has 0 employees.

What is the current trading status of Pharmala Biotech Holdings (MDMA)?

As of 26 Aug 2025, Pharmala Biotech Holdings (MDMA) is trading at a price of 0.12, with a previous close of 0.08. The stock has fluctuated within a day range of 0.12 to 0.14, while its 52-week range spans from 0.07 to 0.34.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.